The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review. (Q36319447)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28333356%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28333356%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

systematic review

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28333356%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Robert Gilchrist

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28333356%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28333356%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

author name string

Rachael J Rodgers

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28333356%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Geoffrey D Reid

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28333356%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Juliette Koch

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28333356%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Rebecca Deans

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28333356%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Michael Friedlander

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28333356%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Jason A Abbott

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28333356%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

language of work or name

0 references

publication date

1 May 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28333356%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Human Reproduction

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28333356%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

32

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28333356%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1033-1045

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28333356%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28333356%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Preserving fertility in cancer patients.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Tamoxifen and pregnancy

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Serum but not follicular fluid cytokine levels are increased in stimulated versus natural cycle IVF: a multiplexed assay study.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Effect of estradiol on oocyte development

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

The Outcome of 150 Babies Following the Treatment With Letrozole or Letrozole and Gonadotropins

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Use of tamoxifen before and during pregnancy

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Neoadjuvant Bevacizumab plus Chemotherapy versus Chemotherapy Alone to Treat Non-Metastatic Breast Cancer: A Meta-Analysis of Randomised Controlled Trials

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

The effects of letrozole on ovarian stimulation for fertility preservation in cancer-affected women.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

The role of the insulin-like growth factor-1 system in breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Teratogenic effects of clomiphene, tamoxifen, and diethylstilbestrol on the developing human female genital tract

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Estradiol promotes growth and angiogenesis in polyoma middle T transgenic mouse mammary tumor explants

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

In-vitro fertilization in completely natural cycles.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Steroid hormones, steroid receptors, and breast cancer stem cells

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Androgens and musculoskeletal symptoms among breast cancer patients on aromatase inhibitor therapy

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Special Issues in Younger Women with Breast Cancer.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Letrozole is superior to anastrozole in suppressing breast cancer tissue and plasma estrogen levels

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

GnRH agonist for triggering of final oocyte maturation: time for a change of practice?

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Long-Term Safety of Letrozole and Gonadotropin Stimulation for Fertility Preservation in Women With Breast Cancer

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Does higher starting dose of FSH stimulation with letrozole improve fertility preservation outcomes in women with breast cancer?

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Letrozole versus clomiphene for infertility in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Peripheral levels of vascular endothelial growth factor (VEGF) are higher in gonadotropin stimulated as compared to natural ovarian cycles.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Estrogen-Induced Ets-1 Promotes Capillary Formation in an in vitro Tumor Angiogenesis Model

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Estradiol production during controlled ovarian hyperstimulation correlates with treatment outcome in women undergoing in vitro fertilization-embryo transfer.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

The effects of peak and mid-luteal estradiol levels on in vitro fertilization outcome.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Predictive value of serum oestradiol concentrations and oocyte number in severe ovarian hyperstimulation syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Web-based survey of fertility issues in young women with breast cancer.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Fertility preservation: a vital survivorship issue for young women with breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Impact of elevated peak serum estradiol levels during controlled ovarian hyperstimulation on the birth weight of term singletons from fresh IVF-ET cycles

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Estrogen signaling through the transmembrane G protein-coupled receptor GPR30.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Ovarian stimulation for fertility preservation in patients with cancer

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

What does an orphan G-protein-coupled receptor have to do with estrogen?

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: an extended experience

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Is letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer?

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Prospective study of fertility concerns and preservation strategies in young women with breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Congenital malformations among babies born following letrozole or clomiphene for infertility treatment

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

The effect of paclitaxel and nab-paclitaxel in combination with anti-angiogenic therapy in breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Maternal serum oestrogen and androgen concentrations in preeclamptic and uncomplicated pregnancies

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

High serum estradiol levels are not detrimental to in vitro fertilization outcome.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEX027

21 January 2018

Identifiers

10.1093/HUMREP/DEX027

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28333356%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28333356%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36319447&oldid=1519444323"